معرفی
Jamie Lynn Todd is an Associate Professor of Medicine at Duke University School of Medicine and a member of the Duke Clinical Research Institute, specializing in lung transplantation and advanced lung disease with a focus on idiopathic pulmonary fibrosis (IPF). Her work bridges clinical practice and translational research to address critical challenges in pulmonary medicine.
Education:
- Fellow in Pulmonary Medicine, Duke University (2008-2009)
- Resident, Duke University, Medicine (2005-2008)
- M.D., University of Colorado, School of Medicine (2005)
Research Focus: Dr. Todd investigates clinical and genetic risk factors for lung fibrosis in transplant rejection and IPF, and examines how airway epithelial injury responses influence repair, fibrosis, and immunity. Her approach integrates molecular biology with clinical data to develop predictive models and biomarkers for disease progression.
Publication Trends: Her 2025 publications emphasize biomarker discovery (prostasin, hyaluronan), risk stratification in lung transplantation, and environmental impacts on IPF. Utilizing large registries like IPF-PRO and ILD-PRO, her work prioritizes practical applications for early detection and intervention in fibrotic lung diseases.
Grants & Collaboration: As PI on 10 active grants (2019-2029), including NIH K23 and Cystic Fibrosis Foundation awards, she leads the Lung Transplant Clinical Trial Network and Duke PROSPER training program. Her extensive grant portfolio supports translational research and mentorship in pulmonary academia.
Research Ecosystem: Embedded in Duke's Department of Medicine and Clinical Research Institute, she collaborates with the Lung Transplant Outcomes Group and IPF-PRO Registry teams, driving multicenter studies that shape clinical guidelines for transplant complications and fibrotic lung diseases.
